News WuXi Biologics (Cayman) Inc. OTC Markets

Equities

WXXW.Y

US98260N1081

Market Closed - OTC Markets Other stock markets 20:59:27 29/05/2024 BST			5-day change	1st Jan Change
2.88 ^USD	-2.24%		-13.04%	-61.34%

05-27	China stocks rise as industrial profits grow; energy, semiconductor shares lead gains	RE
05-17	Wuxi Biologics (Cayman) Maintains it is Not a Security Threat After House Bill Changes; Stocks Drop 3%	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

China stocks rise as industrial profits grow; energy, semiconductor shares lead gains	05-27	RE
Wuxi Biologics (Cayman) Maintains it is Not a Security Threat After House Bill Changes; Stocks Drop 3%	05-17	MT
US House committee advances bill to restrict BGI, WuXi AppTec	05-15	RE
US House committee to vote on bill to restrict BGI, WuXi AppTec	05-15	RE
US Congress Drafts Bill Asking Drug Firms to Unlink from Chinese Biotech Firms	05-14	MT
WuXi Shares Volatile as U.S. Bill Revised to Set Deadline for Decoupling	05-13	DJ
U.S. bill to restrict WuXi AppTec, other Chinese biotech cos revised to give more time to cut ties	05-10	RE
Pacific Assets Trust cautiously optimistic after outpacing benchmark	04-30	AN
WuXi Biologics Cayman : Releases 2023 ESG Report Demonstrating Strong Sustainability Commitment	04-30	PU
WuXi Biologics Selected for S&P Global Sustainability Yearbook 2024	04-16	AQ
WuXi Biologics Wins 2024 CDMO Leadership Awards in All Categories	04-03	AQ
Wuxi Biologics Inc. Announces Retirement of Weichang Zhou as Chief Technology Officer and President of Global Biologics Development and Operations and Re-Designates as Non-Executive Director and Honorary President of Global Biologics Development and Operations and Senior Advisor to Chief Executive Officer	04-01	CI
WuXi Biologics Reports Solid 2023 Annual Results	03-27	AQ
WuXi Biologics' 2023 Profit Falls 23% Despite Revenue Jump	03-27	MT
WuXi Biologics 2023 Net Profit Fell on Higher Expenses, Impairment Losses	03-27	DJ
WuXi Biologics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-26	CI
WuXi Biologics Named to CDP 'A List' for Water Security	03-25	AQ
WuXi Biologics Cayman : Breaks Ground on CRDMO Center in Singapore	03-19	PU
Hong Kong Shares Slip Amid Downbeat Earnings, Cautious Trade	03-19	MT
WuXi AppTec's Shares Fall After Downbeat Guidance	03-19	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News WuXi Biologics (Cayman) Inc. OTC Markets

Equities

WXXW.Y

US98260N1081

Summary

Filters